APA (7th ed.) Citation

Lurje, I., & Tacke, F. (2024). Resmetirom for metabolic dysfunction-associated steatohepatitis: Targeting hepatic and cardiovascular disease : editorial commentary. Hepatobiliary surgery and nutrition, 13(6), . https://doi.org/10.21037/hbsn-24-568

Chicago Style (17th ed.) Citation

Lurje, Isabella, and Frank Tacke. "Resmetirom for Metabolic Dysfunction-associated Steatohepatitis: Targeting Hepatic and Cardiovascular Disease : Editorial Commentary." Hepatobiliary Surgery and Nutrition 13, no. 6 (2024). https://doi.org/10.21037/hbsn-24-568.

MLA (9th ed.) Citation

Lurje, Isabella, and Frank Tacke. "Resmetirom for Metabolic Dysfunction-associated Steatohepatitis: Targeting Hepatic and Cardiovascular Disease : Editorial Commentary." Hepatobiliary Surgery and Nutrition, vol. 13, no. 6, 2024, https://doi.org/10.21037/hbsn-24-568.